Lamellar body mimetics with potential therapeutic applications.

News & Press

Lamellar Biomedical Ltd is pleased to provide you with news and information on the Company and its areas of interest:



Press release: February 2014


Lamellar Biomedical CEO Presented at Realising the Potential of Life Sciences in Scotland this week



Press release: December 2013


ISO 9001:2008 awarded December 2013



Press release: September 2013


University of Edinburgh, Roslin Institute, Edinburgh - Studentship awarded


Lamellar Biomedical in conjuction with Roslin Institute, University of Edinburgh have been successfully awarded a 3 year iCASE PhD studentship



Press release: June 2013


ISO 13845:2003 awarded June 2013



Press release: 7 January 2013


Lamellar Biomedical raises £3.3 million from Instituational investors


Lamellar Biomedical is pleased to announce that it has raised £3.3 million in equity financing from existing and new

shareholders including Barwell, Scottish Enterprise and TRI Cap angel investors. Funds managed by Invesco Perpetual

form the core of the new shareholding.



Press Release: November 2012


University of Glasgow, Glasgow - 4 year Studentship awarded



Press Release: September 2011


University of Strathclyde, Glasgow - SULSA Studentship awarded


Press release: 16 June 2011

Lamellar Biomedical Secures its First Orphan Drug Licence

Provides 10-year Market Exclusivity for the treatment of Cystic Fibrosis

Glasgow biopharmaceutical firm, Lamellar Biomedical Ltd, launched four years ago to develop a new class of therapies for the prevention, treatment and control of severe respiratory disease, today announced that their lead clinical candidate LMS-611 for the treatment of patients with cystic fibrosis has ... more>>

Press release: 18-21 May 2009

Lamellar Biomedical took its science and Lamellasomes abroad to the BIO International Convention, Philadelphia, USA

Press release: 12-14 October 2008

Lamellar Biomedical made a podium presentation at the 2008 BioPartnering Europe conference in London, UK

Press release: 18 September 18 2008

Young Company Finance invited Lamellar Biomedical Ltd to present at their annual conference in Stirling, UK

Press release: 17 September 2007

Investors Group Pumps 1m Into Lamellar Biomedical (from The Herald)

A Bellshill-based firm, which is planning to pioneer a new treatment for cystic fibrosis and other respiratory diseases, has received a funding boost of nearly £1m from a consortium of investors, instigated by... more>>

For further information please contact Lamellar Biomedical
Tel: +44 (0) 1698 748832       Fax: +44 (0) 1698 849500      Email: